Upstream Bio earnings were -$110.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest UPB earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$40.0M, up 46.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, UPB reported annual earnings of -$76.4M, with 99.7% growth. The next UPB earnings date is Nov 6, 2025.
On UPB's earnings call on Invalid Date, Upstream Bio (NASDAQ: UPB) reported Q2 2025 earnings per share (EPS) of -$0.74, up 88.62% year over year. Total UPB earnings for the quarter were -$39.97 million. In the same quarter last year, Upstream Bio's earnings per share (EPS) was -$6.50.
The next UPB earnings call is Invalid Date. Add UPB to your watchlist to be reminded of Upstream Bio's next earnings date.
Is Upstream Bio profitable or losing money?
As of the last Upstream Bio earnings report, Upstream Bio is currently losing money. Upstream Bio's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$104.47 million, a 157.91% increase year over year.
What was UPB's earnings growth in the past year?
As of Upstream Bio's earnings date in Invalid Date, Upstream Bio's earnings has grown year over year. UPB earnings in the past year totalled -$110.06 million.
What are Upstream Bio's earnings expectations?
The current EPS estimate for Upstream Bio's earnings report in Invalid Date is -$0.77.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.